Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Preferred Shares (2018 - 2019)

Precision Biosciences (DTIL) has disclosed Preferred Shares for 2 consecutive years, with $2000.0 as the latest value for Q1 2019.

  • Quarterly Preferred Shares changed N/A to $2000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Mar 2019, changed N/A year-over-year, with the annual reading at $2000.0 for FY2018, N/A changed from the prior year.
  • Preferred Shares for Q1 2019 was $2000.0 at Precision Biosciences, roughly flat from $2000.0 in the prior quarter.
  • The five-year high for Preferred Shares was $2000.0 in Q4 2018, with the low at $2000.0 in Q4 2018.